These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 20240426)

  • 1. The absence of a direct relation between growth inhibition and sulphur metabolism after 1:2:5:6-dibenzanthracene.
    ELSON LA; GOULDEN F; WARREN FL
    Br J Cancer; 1947 Mar; 1(1):80-6. PubMed ID: 20240426
    [No Abstract]   [Full Text] [Related]  

  • 2. The relation between growth inhibition, toxicity and protein metabolism in rats treated with 1:2:5:6-dibenzanthracene.
    ELSON LA; WARREN FL
    Br J Cancer; 1947 Mar; 1(1):86-97. PubMed ID: 20240427
    [No Abstract]   [Full Text] [Related]  

  • 3. On the filtrability of tumors induced by 1,2,5,6-dibenzanthracene.
    SILBER LA
    Am Rev Sov Med; 1946 Dec; 4(2):100-5. PubMed ID: 20277483
    [No Abstract]   [Full Text] [Related]  

  • 4. A study of the inhibition of tumor growth in mice and rats with 10-methyl-1,2-benzanthracene and derivatives related to the nitrogen and sulfur beta-chloroethyl vesicants.
    SELIGMAN AM; MILDEN M; FRIEDMAN OM
    Cancer; 1949 Jul; 2(4):701-6, tab. PubMed ID: 18149957
    [No Abstract]   [Full Text] [Related]  

  • 5. The inhibitory action of 1:2:5:6-dibenzanthracene on the growth of the Walker carcinoma 256 in rats maintained on high and low protein diets.
    ELSON LA; HADDOW A
    Br J Cancer; 1947 Mar; 1(1):97-101. PubMed ID: 20240428
    [No Abstract]   [Full Text] [Related]  

  • 6. [Inhibition of cancer growth by 1-2-5-6-dibenzanthracene].
    HARANGHY L; GYERGYAY F; ANTALFFY A
    Acta Morphol Acad Sci Hung; 1953; 3(2):183-96. PubMed ID: 13091784
    [No Abstract]   [Full Text] [Related]  

  • 7. Summation and inhibition effects of weak and strong carcinogenic hydrocarbons: 1:2-benzanthracene, chrysene, 1:2:5:6-dibenzanthracene, and 20-methylcholanthrene.
    STEINER PE; FALK HL
    Cancer Res; 1951 Jan; 11(1):56-63. PubMed ID: 14792556
    [No Abstract]   [Full Text] [Related]  

  • 8. On the mechanism of experimental carcinogenesis 4. The early mitotic effect of 9, 10-dimethyl-1, 2-benzanthracene and of 1,2,5, 6-dibenzanthracene on epidermal cells of the mouse ear.
    IVERSEN S; EDELSTEIN JM
    Acta Pathol Microbiol Scand; 1952; 30(2):213-22. PubMed ID: 14933055
    [No Abstract]   [Full Text] [Related]  

  • 9. The induction of the initiating phase of skin carcinogenesis in the mouse by oral administration of 9:10-dimethyl-1:2-benzanthracene, 20-methyl-cholanthrene, 3:4-benspyrene, and 1:2:5:6-dibenzanthracene.
    BERENBLUM I; HARAN-GHERA N
    Br J Cancer; 1957 Mar; 11(1):85-7. PubMed ID: 13436701
    [No Abstract]   [Full Text] [Related]  

  • 10. The metabolic degradation in the mouse of dibenzanthracene labeled in the 9 and 10 positions with carbon 14.
    HEIDELBERGER C; KIRK MR; PERKINS MS
    Cancer; 1948 Jul; 1(2):261-75. PubMed ID: 18875040
    [No Abstract]   [Full Text] [Related]  

  • 11. Derivatives of 10-methyl-1,2-benzanthracene related to the nitrogen and sulfur beta-chloroethyl vesicants.
    FRIEDMAN OM; SELIGMAN AM
    J Am Chem Soc; 1948 Sep; 70(9):3082-6. PubMed ID: 18882543
    [No Abstract]   [Full Text] [Related]  

  • 12. The effect of 1:2:5:6-dibenzanthracene on the ascorbic acid content of the liver of rats maintained on high and low protein diets.
    ELSON LA; KENNAWAY EL; TIPLER MM
    Br J Cancer; 1949 Mar; 3(1):148-56. PubMed ID: 18128328
    [No Abstract]   [Full Text] [Related]  

  • 13. Changes in serum-protein levels in rabbits treated with 1:2:5:6 dibenzanthracene.
    WILLIAMS JL; STANSFIELD R
    Nature; 1949 Aug; 164(4163):272. PubMed ID: 18229093
    [No Abstract]   [Full Text] [Related]  

  • 14. STUDIES ON 1,2:5,6-DIBENZANTHRACENE INDUCED MAMMARY CARCINOGENESIS IN MICE.
    RANADIVE KJ; KARANDE KA
    Br J Cancer; 1963 Jun; 17(2):272-80. PubMed ID: 14042729
    [No Abstract]   [Full Text] [Related]  

  • 15. Surface behavior of dibenzanthracene with lipid monolayers.
    Belmonte AA; Swarbrick J
    Biochim Biophys Acta; 1973 Nov; 323(4):647-52. PubMed ID: 4761097
    [No Abstract]   [Full Text] [Related]  

  • 16. [DETERMINATION OF LOW CONCENTRATIONS OF 1,2,5,6-DIBENZANTHRACENE].
    KOROTKOV PA; SERZHANTOVA NN; TSIASHCHENKO IuP; IANYSHEVA NIa
    Gig Sanit; 1964 Dec; 29():51-5. PubMed ID: 14317564
    [No Abstract]   [Full Text] [Related]  

  • 17. The carcinogenic activities of various derivatives of dibenzanthracene.
    HEIDELBERGER C; BAUMANN ME; GRIESBACH L; GHOBAR A; VAUGHAN TM
    Cancer Res; 1962 Jan; 22():78-83. PubMed ID: 13905968
    [No Abstract]   [Full Text] [Related]  

  • 18. Occurrence of pulmonary tumors in mice of strains A, BL, and SWR and their F1 hybrids following intravenous injection of 1,2,5,6-dibenzanthracene.
    DERINGER MK; HESTON WE
    J Natl Cancer Inst; 1953 Aug; 14(1):127-30. PubMed ID: 13097143
    [No Abstract]   [Full Text] [Related]  

  • 19. On the sensitivity of different tissues in Street strain mice to 9,10-dimethyl-1,2-benzanthracene.
    ENGELBRETH-HOLM J; RASK-NIELSEN R
    Cancer Res; 1947 Mar; 7(3):129-33. PubMed ID: 20289423
    [No Abstract]   [Full Text] [Related]  

  • 20. The distribution of radioactivity in mice following administration of 3,4-benzpyrene-5-C14 and 1,2,5,6-dibenzanthracene-9,10-C14.
    HEIDELBERGER C; WEISS SM
    Cancer Res; 1951 Nov; 11(11):885-91. PubMed ID: 14886940
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.